(1) Sample siting plans.
(a) Systems must develop a written sample
siting plan that identifies sampling sites and a sample collection schedule
that are representative of water throughout the distribution system. These
plans are subject to Director review and revision. Systems must collect total
coliform samples according to the written sample siting plan. Monitoring
required by
R309-211-5,
6 and 7 may take place at a customer's premise, dedicated sampling station, or
other designated compliance sampling location. Routine and repeat sample sites
and any sampling points necessary to meet the requirements of
R309-215-16 must
be reflected in the sampling plan.
(b) Systems must collect samples at regular
time intervals throughout the month, except that systems that use only ground
water and serve 4,900 or fewer people may collect all required samples on a
single day if they are taken from different sites.
(c) Systems must take at least the minimum
number of required samples even if the system has had an E. coli MCL violation
or has exceeded the coliform treatment technique triggers in
R309-211-8(1).
(d) A system may conduct more compliance
monitoring than is required by this rule to investigate potential problems in
the distribution system and use monitoring as a tool to assist in uncovering
problems. A system may take more than the minimum number of required routine
samples and must include the results in calculating whether the coliform
treatment technique trigger in
R309-211-8(1)(a)
(i) and (ii) has been exceeded only if the samples are taken in accordance with
the existing sample siting plan and are representative of water throughout the
distribution system.
(e) Systems
must identify repeat monitoring locations in the sample siting plan. Unless the
provisions of paragraphs (1)(e)(i) or (1) (e)(ii) of this section are met, the
system must collect at least one repeat sample from the sampling tap where the
original total coliform-positive sample was taken, and at least one repeat
sample at a tap within five service connections upstream and at least one
repeat sample at a tap within five service connections downstream of the
original sampling site. If a total coliform-positive sample is at the end of
the distribution system, or one service connection away from the end of the
distribution system, the system must still take all required repeat samples.
However, the Director may allow an alternative sampling location in lieu of the
requirement to collect at least one repeat sample upstream or downstream of the
original sampling site. Except as provided for in paragraph (1)(e)(ii) of this
section, systems required to conduct triggered source water monitoring under
R309-215-16(2)
must take ground water source sample(s) in addition to repeat samples required
under this rule.
(i) Systems may propose
repeat monitoring locations to the Director that the system believes to be
representative of a pathway for contamination of the distribution system. A
system may elect to specify either alternative fixed locations or criteria for
selecting repeat sampling sites on a situational basis in a standard operating
procedure (SOP) in its sample siting plan. The system must design its SOP to
focus the repeat samples at locations that best verify and determine the extent
of potential contamination of the distribution system area based on specific
situations. The Director may modify the SOP or require alternative monitoring
locations as needed.
(ii) Ground
water systems serving 1,000 or fewer people may propose repeat sampling
locations to the Director that differentiate potential source water and
distribution system contamination (e.g., by sampling at entry points to the
distribution system). A ground water system with a single well required to
conduct triggered source water monitoring may, with written Director approval,
take one of its repeat samples at the monitoring location required for
triggered source water monitoring under
R309-215-16(2)(a)
if the system demonstrates to the Director's satisfaction that the sample
siting plan remains representative of water quality in the distribution system.
If approved by the Director, the system may use that sample result to meet the
monitoring requirements in both
R309-215-16(2)(a)
and this section.
(A) If a repeat sample
taken at the monitoring location required for triggered source water monitoring
is E. coli-positive, the system has violated the E. coli MCL and must also
comply with
R309-215-16(2)(a)(iii).
If a system takes more than one repeat sample at the monitoring location
required for triggered source water monitoring, the system may reduce the
number of additional source water samples required under
R309-215-16(2)(a)(iii)
by the number of repeat samples taken at that location that were not E.
coli-positive.
(B) If a system
takes more than one repeat sample at the monitoring location required for
triggered source water monitoring under
R309-215-16(2)(a),
and more than one repeat sample is E. coli-positive, the system has violated
the E. coli MCL and must also comply with
R309-215-16(3)(a)(i).
(C) If all repeat samples taken at the
monitoring location required for triggered source water monitoring are E.
coli-negative and a repeat sample taken at a monitoring location other than the
one required for triggered source water monitoring is E. coli-positive, the
system has violated the E. coli MCL, but is not required to comply with
R309-215-16(2)(a)(iii).
(f) The Director may
review, revise, and approve, as appropriate, repeat sampling proposed by
systems under paragraphs (1)(e)(i) and (ii) of this section. The system must
demonstrate that the sample siting plan remains representative of the water
quality in the distribution system. The Director may determine that monitoring
at the entry point to the distribution system (especially for undisinfected
ground water systems) is effective to differentiate between potential source
water and distribution system problems.
(2) Special purpose samples. Special purpose
samples, such as those taken to determine whether disinfection practices are
sufficient following pipe placement, replacement, or repair, must not be used
to determine whether the coliform treatment technique trigger has been
exceeded. Repeat samples taken pursuant to
R309-211-7 are not considered special purpose samples, and must be used to determine
whether the coliform treatment technique trigger has been exceeded.
(3) Invalidation of total coliform samples. A
total coliform-positive sample invalidated under this paragraph (3) of this
section does not count toward meeting the minimum monitoring requirements of
this subpart.
(a) The Director may invalidate
a total coliform-positive sample only if the conditions of paragraph (3)(a)(i),
(ii), or (iii) of this section are met.
(i)
The laboratory establishes that improper sample analysis caused the total
coliform-positive result.
(ii) The
Director, on the basis of the results of repeat samples collected as required
under
R309-211-7(1),
determines that the total coliform-positive sample resulted from a domestic or
other non-distribution system plumbing problem. The Director cannot invalidate
a sample on the basis of repeat sample results unless all repeat sample(s)
collected at the same tap as the original total coliform-positive sample are
also total coliform-positive, and all repeat samples collected at a location
other than the original tap are total coliform-negative (e.g., a Director
cannot invalidate a total coliform-positive sample on the basis of repeat
samples if all the repeat samples are total coliform-negative, or if the system
has only one service connection).
(iii) The Director has substantial grounds to
believe that a total coliform-positive result is due to a circumstance or
condition that does not reflect water quality in the distribution system. In
this case, the system must still collect all repeat samples required under
R309-211-7(1),
and use them to determine whether a coliform treatment technique trigger in
R309-211-8 has been exceeded. To invalidate a total coliform-positive sample under this
paragraph, the decision and supporting rationale must be documented in writing,
and approved and signed by the supervisor of the Director who recommended the
decision. The Director must make this document available to EPA and the public.
The written documentation must state the specific cause of the total
coliform-positive sample, and what action the system has taken, or will take,
to correct this problem. The Director may not invalidate a total
coliform-positive sample solely on the grounds that all repeat samples are
total coliform-negative.
(b) A laboratory must invalidate a total
coliform sample (unless total coliforms are detected) if the sample produces a
turbid culture in the absence of gas production using an analytical method
where gas formation is examined (e.g., the Multiple-Tube Fermentation
Technique), produces a turbid culture in the absence of an acid reaction in the
Presence-Absence (P-A) Coliform Test, or exhibits confluent growth or produces
colonies too numerous to count with an analytical method using a membrane
filter (e.g., Membrane Filter Technique). If a laboratory invalidates a sample
because of such interference, the system must collect another sample from the
same location as the original sample within 24 hours of being notified of the
interference problem, and have it analyzed for the presence of total coliforms.
The system must continue to re-sample within 24 hours and have the samples
analyzed until it obtains a valid result. The Director may waive the 24-hour
time limit on a case-by-case basis. Alternatively, the Director may implement
criteria for waiving the 24hour sampling time limit to use in lieu of
case-by-case extensions.
(4) A public water system that uses
inadequately treated surface water or inadequately treated ground water under
the direct influence of surface water (R309-200 and R309-215) shall collect and
analyze for total coliforms at least one sample each day the turbidity level of
the source water, measured as specified in
R309-200-4(3),
exceeds 1 NTU. This sample shall be collected near the first service connection
from the source. The system shall collect the sample within 24 hours of the
time when the turbidity level was first exceeded.
The sample shall be analyzed within 30 hours of collection.
Sample results from this coliform monitoring shall be included in determining
total coliform compliance for that month. The Director may extend the 24 hour
limitation if the system has a logistical problem that is beyond the system's
control. In the case of an extension the Director shall specify how much time
the system has to collect the sample.